TET2 and lymphoma: Tet2 knockout mice partially phenocopied DLBCL patients, characterized by downregulation of antigen presentation genes/interferon pathway, lymphoma-like transcriptional profiles similar to CREBBP-mutant patients, and a failure at the germinal center exit.